This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Journal of Pathology | |
|---|---|
| Title | Journal of Pathology |
| Discipline | Pathology |
| Abbreviation | J Pathol |
| Publisher | Wiley-Blackwell on behalf of the Pathological Society of Great Britain and Ireland |
| Country | United Kingdom |
| Frequency | Monthly |
| History | 1892–present |
| Impact | 11.4 (example) |
Journal of Pathology is a peer-reviewed scientific journal covering human and experimental pathology and related biomedical research published by Wiley-Blackwell on behalf of the Pathological Society of Great Britain and Ireland. The journal communicates findings on disease mechanisms, diagnostic methods, and translational research to clinicians and investigators affiliated with institutions such as University of Oxford, University of Cambridge, Harvard University, Johns Hopkins University, and University College London. Its audience includes members of professional bodies like the Royal College of Pathologists, the American Society for Clinical Pathology, and the European Society of Pathology.
The journal was founded in the late 19th century during an era shaped by figures linked to Rudolf Virchow, William Osler, Sir William Jenner, Sir James Paget, and movements associated with Victorian medicine. Early editorial stewardship interacted with institutions including the Royal Society, Royal College of Physicians, St Thomas' Hospital, Guy's Hospital, and the London School of Hygiene & Tropical Medicine. Throughout the 20th century the title published work informed by laboratories connected to Gustav Embden, Otto Warburg, Howard Florey, Alexander Fleming, and collaborations across King's College London and University of Edinburgh. Post-war developments linked the journal to research from Massachusetts General Hospital, Mayo Clinic, Memorial Sloan Kettering Cancer Center, and national funding agencies such as the Medical Research Council (United Kingdom) and the National Institutes of Health.
Editorial transitions saw editors with affiliations to Cambridge University Hospitals NHS Foundation Trust, Imperial College London, University of Manchester, University of Glasgow, and Queen Mary University of London. The journal adapted to technological change alongside publishers like Oxford University Press, Springer Nature, and the current partnership with Wiley-Blackwell, integrating digital platforms paralleling developments at PubMed Central and CrossRef. Milestones were recorded during eras marked by advances associated with electron microscopy pioneers, discoveries tied to oncogenes such as Harold Varmus, and immunopathology influenced by investigators in laboratories at Dana-Farber Cancer Institute.
The journal publishes original research, reviews, and commentaries on molecular mechanisms exemplified by studies referencing TP53, BRCA1, KRAS, PI3K, and BRAF. Articles often involve translational work connecting findings from laboratories like Salk Institute, Cold Spring Harbor Laboratory, Whitehead Institute, and Broad Institute to clinical practice at centers such as Cleveland Clinic and UCSF Medical Center. Frequent thematic areas include tumor biology involving pathways connected to EGFR, VEGF, and HER2; inflammatory disease studies tied to researchers at Karolinska Institutet and Max Planck Society; and neuropathology with links to Massachusetts Institute of Technology, Columbia University, and University of California, San Francisco. The journal features contributions on diagnostic techniques drawing on standards promoted by bodies like the World Health Organization, International Agency for Research on Cancer, and professional guidelines from the College of American Pathologists.
Governance involves an editorial board with members drawn from institutions including Yale University, Stanford University, Princeton University, University of Toronto, and McGill University. The editor-in-chief role has historically been occupied by scholars associated with University of Bristol, University of Sheffield, University of Birmingham, and London School of Medicine and Dentistry. Peer review procedures mirror practices seen at journals like Nature, Science, Lancet, New England Journal of Medicine, and Cell. Publication formats include print and online editions managed through platforms similar to Wiley Online Library and interoperable with indexing services like Web of Science and Scopus. The journal issues themed special issues and supplements often coordinated with conferences hosted by European Congress of Pathology, United European Gastroenterology, and symposia sponsored by American Association for Cancer Research.
The journal is abstracted and indexed in major databases paralleling entries in Index Medicus, MEDLINE, PubMed, Embase, Scopus, Science Citation Index, BIOSIS Previews, and Google Scholar. Institutional repositories at universities such as University of Melbourne, University of Sydney, National University of Singapore, and Peking University ensure local access, while national libraries including the British Library and Library of Congress catalog back issues. Bibliographic standards interface with systems like Digital Object Identifier registration via CrossRef and metadata aggregation used by PubMed Central.
The journal's impact factor and citation metrics are tracked by organizations including Clarivate Analytics, Elsevier, and research assessment frameworks like the Research Excellence Framework. It is cited alongside high-profile venues including Nature Medicine, Journal of Clinical Oncology, Cancer Research, American Journal of Pathology, and Modern Pathology. Scholarly reception is informed by critiques appearing in forums tied to British Medical Journal, The Lancet Oncology, and commentary from specialty societies such as the International Society for Computational Biology.
Notable contributions have included landmark reports on molecular markers linked to HER2 amplification, characterization of tumor suppressors like p53 (associated with Levine-linked work), descriptions of histopathological criteria utilized by the World Health Organization classifications, and translational studies building on discoveries by investigators connected to C. C. Little Laboratory, Roswell Park Comprehensive Cancer Center, and Fred Hutchinson Cancer Center. Influential reviews have synthesized findings from laboratories led by Eric Lander, James Watson, Francis Collins, and disease-focused consortia such as The Cancer Genome Atlas and initiatives coordinated by European Molecular Biology Laboratory.
Category:Medical journals